While Armistice Capital is primarily known among institutional investors for its healthcare and biopharma holdings, its 13F filings show a portfolio that extends into retail and consumer sectors as well. The fund, which manages more than $7 billion in assets, has disclosed positions in major retail chains and consumer companies alongside the specialty pharmaceutical stocks that make up the core of its reported holdings. Portfolio diversification beyond a primary sector is a common feature of hedge fund construction, particularly for funds managing capital across different risk profiles.
Armistice’s retail holdings have included positions in companies such as Ross Stores, Foot Locker, and Best Buy, each of which attracts a wide range of institutional investors across different fund types. Large passive managers including Vanguard Group and BlackRock hold substantial equity in these retail names through broad index mandates, while active managers including Armistice participate through more selective position-building. The fund has also disclosed holdings in consumer companies such as Freshpet and Dentsply Sirona, and in beverage sector companies alongside Geode Capital Management and other institutional holders.
For hedge funds with heavy biopharma exposure, retail and consumer positions can serve a balancing function, providing access to earnings-driven stocks with different catalyst profiles than clinical-stage drug developers. Freshpet, a pet food company pursuing a growth strategy focused on expanding refrigerated distribution, and Dentsply Sirona, a dental technology company with a global commercial footprint, represent businesses with different risk profiles than most of Armistice’s healthcare holdings. Their presence in the portfolio reflects an approach that layers sector diversification on top of concentrated biopharma exposure.
Other institutional investors in these consumer and retail names include Point72 Asset Management, Norges Bank, and various index-tracking funds, whose presence reflects their broader mandates. Armistice Capital’s participation alongside these institutions in retail and consumer stocks shows that healthcare-focused hedge funds do not always limit their disclosed portfolios to a single sector, and that active managers may build cross-sector positions as part of a broader effort to manage portfolio risk and correlation.